SHENGDA BIO-PHARM (603079.SH) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct29

SHENGDA BIO-PHARM released FY2025 Q3 earnings on October 29 After-Market BJT, actual revenue CNY 220.55 M, actual EPS CNY 0.0818

01:00

SHENGDA BIO-PHARM released FY2025 9 Months Earnings on October 29 After-Market BJT, actual revenue CNY 621.28 M, actual EPS CNY 0.3029

01:00

Oct22

SHENGDA BIO-PHARM to Release FY2025 Q3 Earnings on October 30 After-Market BJT

00:58

Aug25

SHENGDA BIO-PHARM released FY2025 Q2 earnings on August 25 Pre-Market (BJT), actual revenue CNY 197.5 M, actual EPS CNY 0.091

01:00

Aug18

SHENGDA BIO-PHARM to Release FY2025 Semi-Annual Earnings on August 26, 2025 (BJT)

00:06

Jun6

SDSN's Response to Investor Questions on Project Progress and Folic Acid Price

10:01

Schedules & Filings

Schedules

Filings

Oct29

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 220.55 M, Net Income 15.53 M, EPS 0.0818

Aug26

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug25

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 197.5 M, Net Income 16.1 M, EPS 0.091

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More